Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Hoek van den Hil, Elise F ^a   Keijer, Jaap ^a   Bunschoten, Annelies ^a   Vervoort, Jacques J M ^a   Stankova, Barbora ^b   Bekkenkamp, Melissa ^a   Herreman, Laure ^a   Venema, Dini ^a   Hollman, Peter C H ^a   Tvrzicka, Eva ^b   Rietjens, Ivonne M C M ^a   van Schothorst, Evert M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 REDUCTASE; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; QUERCETIN; TRIACYLGLYCEROL;

ACYL COA THIOESTERASE 3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONSTITUTIVE ANDROSTANE RECEPTOR GENE; CONTROLLED STUDY; CYTOCHROME P450 4A10 GENE; CYTOCHROME P450 4A14 GENE; CYTOCHROME P450 4A31 GENE; CYTOCHROME P450 OXIDOREDUCTASE GENE; DRUG EFFECT; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID OMEGA OXIDATION; GAS CHROMATOGRAPHY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPID ANALYSIS; LIPID DIET; LIPID STORAGE; LIVER WEIGHT; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS, UNSATURATED; LIPID METABOLISM; LIPIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; QUERCETIN;

MUS;

EID: 84872837874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051588     Document Type: Article

References (43)

1. van't Veer P, Jansen MC, Klerk M, Kok FJ, (2000) Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr 3: 103-107.
2. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong C-P, et al. (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. The American Journal of Clinical Nutrition 85: 895-909.
3. Arts IC, Hollman PC, (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81: 317S-325S.
4. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D, (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011.
5. Hollman PC, Geelen A, Kromhout D, (2010) Dietary flavonol intake may lower stroke risk in men and women. J Nutr 140: 600-604.
6. Boden G, (2008) Obesity and Free Fatty Acids. Endocrinology & Metabolism Clinics of North America 37: 635-646.
7. Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES, Dallinga-Thie GM, (2009) Triglycerides and cardiovascular risk. Curr Cardiol Rev 5: 216-222.
8. Jouven X, Charles MA, Desnos M, Ducimetiere P, (2001) Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104: 756-761.
9. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, et al. (2006) Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease. J Clin Endocrinol Metab 91: 2542-2547.
10. de Boer VC, van Schothorst EM, Dihal AA, van der Woude H, Arts IC, et al. (2006) Chronic quercetin exposure affects fatty acid catabolism in rat lung. Cell Mol Life Sci 63: 2847-2858.
11. Jung CH, Cho I, Ahn J, Jeon TI, Ha TY (2012) Quercetin Reduces High-Fat Diet-Induced Fat Accumulation in the Liver by Regulating Lipid Metabolism Genes. Phytother Res.
12. Kobori M, Masumoto S, Akimoto Y, Oike H, (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 55: 530-540.
13. Hoek-van den Hil EF, Beekmann K, Keijer J, Hollman PC, Rietjens IM, et al. (2012) Interference of flavonoids with enzymatic assays for the determination of free fatty acid and triglyceride levels. Anal Bioanal Chem 402: 1389-1392.
14. Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, et al. (2012) Fatty acids in cardiovascular health and disease: A comprehensive update. J Clin Lipidol 6: 216-234.
15. Tukiainen T, Tynkkynen T, Makinen VP, Jylanki P, Kangas A, et al. (2008) A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun 375: 356-361.
16. Vinaixa M, Rodriguez MA, Rull A, Beltran R, Blade C, et al. (2010) Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res 9: 2527-2538.
17. Fiorini RN, Kirtz J, Periyasamy B, Evans Z, Haines JK, et al. (2004) Development of an unbiased method for the estimation of liver steatosis. Clin Transplant 18: 700-706.
18. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
19. Carlson LA, (1985) Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol. Clin Chim Acta 149: 89-93.
20. van Schothorst EM, Pagmantidis V, de Boer VC, Hesketh J, Keijer J, (2007) Assessment of reducing RNA input for Agilent oligo microarrays. Anal Biochem 363: 315-317.
21. Pellis L, Franssen-van Hal NL, Burema J, Keijer J, (2003) The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 16: 99-106.
22. Hochberg Y, Benjamini Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
23. Kobayashi Y, Miyazawa M, Kamei A, Abe K, Kojima T, (2010) Ameliorative effects of mulberry (Morus alba L.) leaves on hyperlipidemia in rats fed a high-fat diet: induction of fatty acid oxidation, inhibition of lipogenesis, and suppression of oxidative stress. Biosci Biotechnol Biochem 74: 2385-2395.
24. Lavoie JM, Gauthier MS, (2006) Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 63: 1393-1409.
25. Hsu MH, Savas U, Griffin KJ, Johnson EF, (2007) Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39: 515-538.
26. Reddy JK, Rao MS, (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-858.
27. Hardwick JP, Osei-Hyiaman D, Wiland H, Abdelmegeed MA, Song BJ, (2009) PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease. PPAR Res 2009: 952734.
28. Hardwick JP, (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 75: 2263-2275.
29. Hunt MC, Yamada J, Maltais LJ, Wright MW, Podesta EJ, et al. (2005) A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. J Lipid Res 46: 2029-2032.
30. Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK, (2010) Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog Lipid Res 49: 366-377.
31. Hoch U, Zhang Z, Kroetz DL, Ortiz de Montellano PR, (2000) Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch Biochem Biophys 373: 63-71.
32. Zordoky BN, El-Kadi AO, (2010) Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 125: 446-463.
33. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, et al. (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 278: 13480-13486.
34. Mutch DM, Klocke B, Morrison P, Murray CA, Henderson CJ, et al. (2007) The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism. J Proteome Res 6: 3976-3984.
35. Mutch DM, Crespy V, Clough J, Henderson CJ, Lariani S, et al. (2006) Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver. Am J Physiol Gastrointest Liver Physiol 291: G63-72.
36. Finn RD, Henderson CJ, Scott CL, Wolf CR, (2009) Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway. Biochem J 417: 43-54.
37. Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, et al. (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A 106: 18831-18836.
38. Venkatesan N, Davidson MB, Simsolo RB, Kern PA, (1994) Phenobarbital treatment enhances insulin-mediated glucose metabolism and improves lipid metabolism in the diabetic rat. Metabolism 43: 348-356.
39. Baskin-Bey ES, Anan A, Isomoto H, Bronk SF, Gores GJ, (2007) Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse. World J Gastroenterol 13: 5635-5641.
40. Li L, Stanton JD, Tolson AH, Luo Y, Wang H, (2009) Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 26: 872-882.
41. Yao R, Yasuoka A, Kamei A, Kitagawa Y, Tateishi N, et al. (2010) Dietary flavonoids activate the constitutive androstane receptor (CAR). J Agric Food Chem 58: 2168-2173.
42. Hernandez JP, Mota LC, Baldwin WS, (2009) Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. Curr Pharmacogenomics Person Med 7: 81-105.
43. Sundseth SS, Waxman DJ, (1992) Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J Biol Chem 267: 3915-3921.